Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
SQZ Biotech
Special Reports
The 2024 Biotech Graveyard
Beware: ghosts of biotech’s past.
Gabrielle Masson
Oct 31, 2024 5:00am
SQZ opts for liquidation, $11.8M asset fire sale to Stemcell
Mar 1, 2024 10:20am
SQZ founder Armon Sharei opens Portal to cell engineering
Dec 12, 2023 6:00am
SQZ lays off 80% of staff, Regenxbio cuts 15%
Nov 9, 2023 8:23am
Roche drops solid tumor option, intensifying the squeeze on SQZ
Jul 25, 2023 8:53am
New CEO will lead Teva at top of new year—Chutes & Ladders
Dec 2, 2022 9:30am
